GlassScriptPhysician profile
Carlos Sanchez
NPI 1942201298
$2,530.79
in general payments reported to CMS, 2019-2025
16 companies · $677 in 2025
The $677 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $336 · 2021: $475 · 2022: $127 · 2023: $447 · 2024: $146 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955 · Entertainment: $298 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.69 |
| Entertainment | $297.69 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $483.54 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $279.36 | 2025 | Precision7, Tryptyr |
| Coopervision INC. | $198.39 | 2021-2025 | Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $188.86 | 2020-2021 | |
| Optovue, INC. | $178.39 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $154.95 | 2019 | |
| Biotissue Holdings INC. | $147.19 | 2025 | |
| Bausch & Lomb Americas INC. | $138.20 | 2024-2025 | Infuse, Miebo |
| Rxsight INC | $128.57 | 2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $124.01 | 2020-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $121.66 | 2023 | Cequa |
| Dompe US, INC. | $121.45 | 2021 | |
| Ocular Therapeutix, INC. | $91.51 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $71.75 | 2019 | |
| Allergan, INC. | $67.78 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionix USA, INC | $35.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.